Statin Therapy Before Transition to End‐Stage Renal Disease With Posttransition Outcomes

Statin Therapy Before Transition to End‐Stage Renal Disease With Posttransition Outcomes

Background Although studies have shown that statin therapy in patients with non–dialysis‐dependent chronic kidney disease was associated with a lower risk of death, this was not observed in dialysis patients newly initiated on statins. It is unclear if statin therapy benefits administered during the...

Full description

Bibliographic Details
Main Authors: Melissa Soohoo, Hamid Moradi, Yoshitsugu Obi, Connie M. Rhee, Elvira O. Gosmanova, Miklos Z. Molnar, Moti L. Kashyap, Daniel L. Gillen, Csaba P. Kovesdy, Kamyar Kalantar‐Zadeh, Elani Streja
Format: Article
Language:English
Published: Wiley 2019-03-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
end‐stage renal disease
lipids
mortality
statin
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.011869

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.011869

Similar Items